Inhibiting NR3C1 or disrupting SEs restores the sensitivity of gastric cancer cells to 5-FU, underscoring the key contribution of LLPS in regulating SE-related chemoresistance (Yu et al., 2025). The gene discussed is NR3C1; the disease is gastric cancer.